2090064-66-5

2090064-66-5 structure

Name: Vebicorvir
Chemical Name: 11-Oxo-N-{[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl}-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5,5-dioxide
CAS Number: 2090064-66-5
Molecular Formula: C₁₉H₁₂F₃N₃O₄S₂
Molecular Weight: 467.44
Catalog: Signaling Pathways Anti-infection HBV
Create Date: 2021-12-19 13:34:16
Modify Date: 2024-01-14 09:03:58
Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor. Vebicorvir (ABI-H0731) suppresses covalently closed circular DNA (cccDNA) formation in two de novo infection models with EC50s from 1.84 μM to 7.3 μM[1].

Name	11-Oxo-N-{[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl}-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5,5-dioxide
Synonyms	11-Oxo-N-{[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl}-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide 5,5-dioxide Dibenzo[b,f][1,4]thiazepine-8-carboxamide, 10,11-dihydro-11-oxo-N-[[2-(trifluoromethyl)-5-thiazolyl]methyl]-, 5,5-dioxide

Description	Vebicorvir (ABI-H0731) is a first-generation hepatitis B virus (HBV) core protein inhibitor. Vebicorvir (ABI-H0731) suppresses covalently closed circular DNA (cccDNA) formation in two de novo infection models with EC50s from 1.84 μM to 7.3 μM[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> HBV Research Areas >> Inflammation/Immunology
In Vitro	Vebicorvir (ABI-H0731) demonstrates inhibition of pgRNA, HBeAg, and HBsAg production, with EC50s of 2.68 μM, 4.95 μM, and 7.30 μM, respectively[1]. Vebicorvir (ABI-H0731) is an inhibitor of pgRNA encapsidation and rcDNA synthesis[1].
In Vivo	After i.v. administration, the drug rapidly distributes and decayes in a biphasic manner in all species tested. Plasma clearance values of ABI-H0731 were 8.05, 10.1, 14.7, and 4.86 ml/min/kg, representing 9, 16, 47, and 11% of liver blood flow, in mouse, rat, dog, and monkey, respectively[1].
References	[1]. Qi Huang, et al. Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01463-20.